Reprogramming Disulfide Reduction in Endoplasmic Reticulum Uncouples Immune Evasion of Pancreatic Cancer
Advanced Materials · 2026
DOI: 10.1002/adma.202517261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Zhongqiu Guo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Endoplasmic Reticulum, Disulfides. Die Arbeit nennt 48 Literaturangaben. Gefördert von: The Major Research Plan of National Natural Science Foundation of China, Major Program of National Natural Science Foundation of China, Innovation Program of Shanghai Municipal Education Commission.
Abstract (Originalsprache)
The modulation of immune checkpoint activity exerts profound impacts on tumor immunotherapy. However, the interfere of mature immune checkpoints encounter efficacy challenges in solid tumors, which underlies a critical barrier in clinical translation of multiple potential targets. Herein, we propose a biochemical immune modulation strategy for immunosuppression reversal by blocking the mature of CD47 within the endoplasmic reticulum (ER). Clinically used radionuclides iodine‐131 ( 131 I) is reengineered to encapsulate within microporous barium titanate nanoparticles, forming an immunoactive nanomodulator. Leveraging polarized and collisional relaxation, the electrons emitted from 131 I mediate continuous disulfide bond reduction, blocking CD47 folding and surface translocation, resulting in a 93.6% reduction in CD47 expression. Together with the remarkable increase of tumor antigen presentation induced by ER reductive stress in pancreatic tumor‐bearing mice, we realize a 93% tumor inhibition and a 3‐fold prolongation of survival. This work underscores the role of organellar biochemistry in reshaping immunosuppression for tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, P. R. China.
- State Key Laboratory of Molecular Engineering of Polymers, College of Smart Materials and Future Energy, Fudan University, Shanghai, P. R. China.
- Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, P. R. China.
- Institute of Hepatobiliary and Pancreatic Surgery, Department of Hepatobiliary and Pancreatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, P. R. China.
ORCID-Profile: Wenbo Bu
Förderung
- The Major Research Plan of National Natural Science Foundation of China
- Major Program of National Natural Science Foundation of China
- Innovation Program of Shanghai Municipal Education Commission
- Key Program of National Natural Science Foundation of China
- Special Foundation for Emerging Interdisciplinary Field Research of Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Basic medical research project of the First Affiliated Hospital of Naval Medical University
- National Science Foundation for the Young Scientists of China
Zitieren
APA
Guo, Z., Lu, Y., Zhang, L., Chen, Y., Li, H., Wang, T., Gu, W., Wu, F., Wu, Y., Zhao, P., Zuo, C., & Bu, W. (2026). Reprogramming Disulfide Reduction in Endoplasmic Reticulum Uncouples Immune Evasion of Pancreatic Cancer. Advanced Materials. https://doi.org/10.1002/adma.202517261
Vancouver
Guo Z, Lu Y, Zhang L, Chen Y, Li H, Wang T, et al. Reprogramming Disulfide Reduction in Endoplasmic Reticulum Uncouples Immune Evasion of Pancreatic Cancer. Advanced Materials. 2026. doi:10.1002/adma.202517261
BibTeX
@article{Guo2026,
author = {Guo, Zhongqiu and Lu, Yuting and Zhang, Li and Chen, Yang and Li, Huiyan and Wang, Tao and Gu, Wenjun and Wu, Fan and Wu, Yelin and Zhao, Peiran and Zuo, Changjing and Bu, Wenbo},
title = {Reprogramming Disulfide Reduction in Endoplasmic Reticulum Uncouples Immune Evasion of Pancreatic Cancer},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202517261}
}
EUVIMED